D-0393-2026 Class II Ongoing
FDA drug recall D-0393-2026 was initiated by New Life Pharma LLC on February 26, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 2 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- March 11, 2026
- Initiation Date
- February 26, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2 vials
Product Description
Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
OH
Code Information
Lot 240903, exp 9/30/2026